CGBio NOVOSIS PUTTY Gains FDA Breakthrough Device Designation

CGBio's NOVOSIS PUTTY was granted Breakthrough Device Designation by FDA. This material incorporates recombinant human bone morphogenetic protein 2 (rhBMP-2). NOVOSIS PUTTY’s designation marks the first case for an implantable device in Korea.

NOVOSIS PUTTY, a second-generation product, features a ceramic-based synthetic scaffold with superior...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us